| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972628 | The Journal of Heart and Lung Transplantation | 2007 | 5 Pages |
Abstract
Everolimus allows marked reduction of CsA exposure without significant loss of efficacy and also provides early protection of renal function.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hans B. MD, Daniel Mai, Michael MD, Christoph MD, Nicola E. MD, Onnen MD, Michael MD, Miralem MD, Yuguo MD, Rudolph MD, Markus MD, Manfred MD, Roland MD,